Frontlight ResearchEarly access
CompletedNo phase
Interest of tDCS in Help for Supporting Alcohol Abstinence
Key facts
- Who runs it
- Centre Hospitalier Henri Laborit
- Where
- France2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 90 people enrolled
- Started
- 8 Feb 2017
- Ended
- 7 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active tDCS stimulations
- Sham tDCS
- Record updated
- 13 January 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- patient aged from 18 to 70 years old
- patient free, without guardianship
- absence of epileptic pathology
- patient affiliated to the french health security or benefiting through a third party
- signed informed consent after having received a clear and honest information on the study
- patient with a disorder linked to the use of alcohol (define by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) classification) clinically evaluated
- patient requesting for an alcohol withdrawal
- patient able to read and write
Who cannot take part
- current psychiatric decompensation (mood disorder, suicide risk, psychotic disorders)
- history of cranial traumatism
- patient in emergency condition or unable to give personally her/his consent
- mental illness syndrome and Korsakoff
- patient not affiliated to the french health security or not benefiting through a third party
- woman in reproductive capacity without effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intra-uterine device or chirurgical: tubal ligation, hysterectomy, total ovariectomy) or breastfeeding
- patient hospitalized under duress
- patient with guardianship
- somatic complications during the alcohol withdrawal phase
- patient under benzodiazepines treatment
- patient with scalp cutaneous lesion
- patient with intra-cerebral metallic object
- patient with a pacemaker
- epileptic pathology
- another dependence other than alcohol or tobacco
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.
The 2 groups in the trial
- Active tDCS stimulationsTreatment being tested
Patients in this arm will receive 10 tDCS active stimulations of 2 mA (1 stimulation per day from Monday to Friday during 2 weeks).
- Sham tDCSSham treatment, for comparison
Patients in this arm will receive 10 sham stimulations (1 stimulation per day from Monday to Friday during 2 weeks). As soon as the power will have reached the maximal intensity as in the active arm, the stimulation will be stopped.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 January 2026